These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15975511)

  • 1. Structure-based engineering of E. coli galactokinase as a first step toward in vivo glycorandomization.
    Yang J; Fu X; Liao J; Liu L; Thorson JS
    Chem Biol; 2005 Jun; 12(6):657-64. PubMed ID: 15975511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective detection of sugar phosphates by capillary electrophoresis/mass spectrometry and its application to an engineered E. coli host.
    Hui JP; Yang J; Thorson JS; Soo EC
    Chembiochem; 2007 Jul; 8(10):1180-8. PubMed ID: 17562551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the substrate specificity of Escherichia coli galactokinase.
    Yang J; Fu X; Jia Q; Shen J; Biggins JB; Jiang J; Zhao J; Schmidt JJ; Wang PG; Thorson JS
    Org Lett; 2003 Jun; 5(13):2223-6. PubMed ID: 12816414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creation of the first anomeric D/L-sugar kinase by means of directed evolution.
    Hoffmeister D; Yang J; Liu L; Thorson JS
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13184-9. PubMed ID: 14612558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sugar recognition by human galactokinase.
    Timson DJ; Reece RJ
    BMC Biochem; 2003 Nov; 4():16. PubMed ID: 14596685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure, mechanism and engineering of a nucleotidylyltransferase as a first step toward glycorandomization.
    Barton WA; Lesniak J; Biggins JB; Jeffrey PD; Jiang J; Rajashankar KR; Thorson JS; Nikolov DB
    Nat Struct Biol; 2001 Jun; 8(6):545-51. PubMed ID: 11373625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate specificity and mechanism from the structure of Pyrococcus furiosus galactokinase.
    Hartley A; Glynn SE; Barynin V; Baker PJ; Sedelnikova SE; Verhees C; de Geus D; van der Oost J; Timson DJ; Reece RJ; Rice DW
    J Mol Biol; 2004 Mar; 337(2):387-98. PubMed ID: 15003454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoglycorandomization and chemoenzymatic glycorandomization: two complementary tools for natural product diversification.
    Langenhan JM; Griffith BR; Thorson JS
    J Nat Prod; 2005 Nov; 68(11):1696-711. PubMed ID: 16309329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galactokinase: structure, function and role in type II galactosemia.
    Holden HM; Thoden JB; Timson DJ; Reece RJ
    Cell Mol Life Sci; 2004 Oct; 61(19-20):2471-84. PubMed ID: 15526155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional studies of rat galactokinase.
    Chu X; Li N; Liu X; Li D
    J Biotechnol; 2009 May; 141(3-4):142-6. PubMed ID: 19433218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Sweetening' natural products via glycorandomization.
    Griffith BR; Langenhan JM; Thorson JS
    Curr Opin Biotechnol; 2005 Dec; 16(6):622-30. PubMed ID: 16226456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of a Bacterial Galactokinase with High Activity and Broad Substrate Tolerance for Chemoenzymatic Synthesis of 6-Aminogalactose-1-Phosphate and Analogues.
    Huang K; Parmeggiani F; Pallister E; Huang CJ; Liu FF; Li Q; Birmingham WR; Both P; Thomas B; Liu L; Voglmeir J; Flitsch SL
    Chembiochem; 2018 Feb; 19(4):388-394. PubMed ID: 29193544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant E. coli prototype strains for in vivo glycorandomization.
    Williams GJ; Yang J; Zhang C; Thorson JS
    ACS Chem Biol; 2011 Jan; 6(1):95-100. PubMed ID: 20886903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural product glycorandomization.
    Yang J; Hoffmeister D; Liu L; Fu X; Thorson JS
    Bioorg Med Chem; 2004 Apr; 12(7):1577-84. PubMed ID: 15112655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic implications of Escherichia coli galactokinase structure-based engineering.
    Hoffmeister D; Thorson JS
    Chembiochem; 2004 Jul; 5(7):989-92. PubMed ID: 15239057
    [No Abstract]   [Full Text] [Related]  

  • 16. A highly efficient galactokinase from Bifidobacterium infantis with broad substrate specificity.
    Li L; Liu Y; Wang W; Cheng J; Zhao W; Wang P
    Carbohydr Res; 2012 Jul; 355():35-9. PubMed ID: 22633137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate specificity of galactokinase from Streptococcus pneumoniae TIGR4 towards galactose, glucose, and their derivatives.
    Zou Y; Wang W; Cai L; Chen L; Xue M; Zhang X; Shen J; Chen M
    Bioorg Med Chem Lett; 2012 May; 22(10):3540-3. PubMed ID: 22513283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic optimization via in vitro glycorandomization.
    Fu X; Albermann C; Jiang J; Liao J; Zhang C; Thorson JS
    Nat Biotechnol; 2003 Dec; 21(12):1467-9. PubMed ID: 14608364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The characterisation of a galactokinase from Streptomyces coelicolor.
    Keenan T; Mills R; Pocock E; Budhadev D; Parmeggiani F; Flitsch S; Fascione M
    Carbohydr Res; 2019 Jan; 472():132-137. PubMed ID: 30593944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the promiscuity of a natural-product glycosyltransferase by directed evolution.
    Williams GJ; Zhang C; Thorson JS
    Nat Chem Biol; 2007 Oct; 3(10):657-62. PubMed ID: 17828251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.